Tag: entrepreneurs
-
RNA Therapies Start-Up Raises $55.3M in Early Funds
A start-up company creating treatments for inherited diseases that target faulty RNA transcribed from genetic codes is raising $55.3 million in its first venture funding round.
-
NIH Grant Funds Synthetic Peptide for Severe Asthma
A synthetic peptide, a short chain of amino acids, is being developed as a treatment for severe cases of asthma that do not respond to conventional drugs.
-
Trial Testing Biomarkers as Brain Injury Diagnostics
A clinical trial is underway in Finland testing the ability to detect traumatic brain injuries with simple blood, urine, and saliva tests.
-
FDA Clears Targeted Breast Cancer Radiation Treatment
The U.S. Food and Drug Administration approved a device that sends high doses of radiation to cancerous breast tissue while sparing healthy tissue nearby.
-
Cell Engineering Company Launches, Raises $4.7 Million
A company designing biological circuits with techniques derived from computer-assisted design like those used in semiconductors is starting up in Cambridge, Massachusetts.
-
Super High-Resolution Photo Sensor Developed
Engineers at Dartmouth College developed a sensor that captures light signals at high speed and resolution down to the level of individual photons.
-
Agriculture Tech Start-Up Accelerator to Open
A group supporting start-up companies and entrepreneurs developing new technologies in food and agriculture plans to begin next month in Minneapolis, Minnesota.
-
Emergency Sealant Gel Developed for Eye Injuries
A medical engineering team created a gel material that safely closes injured eye tissue until surgical treatments can be given.
-
Cell Programming Company Raises $49.5M in Early Funds
A start-up enterprise creating add-on treatments that program the effects of cell and gene therapies is raising $49.5 million in its first venture funding round.
-
Engineered Cells Identify Rare Epilepsy Drug Candidates
A process using high-speed screening of drug candidates with genetically engineered cells identified potential drugs to treat a rare form of childhood epilepsy.